Hellerup, Denmark

Claus Bornaes

USPTO Granted Patents = 16 


Average Co-Inventor Count = 3.3

ph-index = 7

Forward Citations = 232(Granted Patents)


Company Filing History:


Years Active: 2003-2015

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Claus Bornaes

Introduction

Claus Bornaes, based in Hellerup, Denmark, is a notable inventor with an impressive portfolio of 16 patents. His work primarily focuses on biochemistry and therapeutic applications, particularly in the field of hemostasis and related medical treatments.

Latest Patents

One of Bornaes' latest innovations includes the development of Factor VII or Factor VIIa Gla domain variants. These variants consist of human Factor VII or human Factor VIIa sequences with specific amino acid modifications, such as introducing hydrophobic amino acid residues in positions 34 and 36. This innovation has significant implications for treating intracerebral hemorrhage (ICH) or trauma. Additionally, he has worked on Factor VII or VIIA-like molecules, which are conjugates of Factor VII and VIIa, including methods for their preparation and therapeutic applications.

Career Highlights

Throughout his career, Claus Bornaes has made substantial contributions to the pharmaceutical field. He has held key positions in prominent companies such as Bayer Healthcare LLC, where he was involved in groundbreaking research and innovation. His expertise has led to advancements in therapeutic methods and the development of novel polypeptides.

Collaborations

Bornaes has collaborated with esteemed professionals, including Kim Vilbour Andersen and Anders Pedersen. These partnerships have fostered fruitful research ventures, enhancing the development of his innovative patents and contributing to the scientific community.

Conclusion

Claus Bornaes stands out as a significant figure in the field of biotechnology, with his innovative patents paving the way for advancements in medical treatments. His dedication and collaboration with other industry professionals continue to inspire progress in the therapeutic landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…